Futurism logo

Vision Care Market: Digital Eye Strain Solutions, Advanced Eye Health, & Growth Trends

The vision care market is growing as more people experience digital eye strain from long hours on computers, phones, and other screens. Innovative solutions like specialized lenses, eye drops, and digital wellness tools help protect and improve eye health.

By James WhitmanPublished about 11 hours ago 4 min read

Key driving factors for the growth of the vision care market include the rising prevalence of vision-related disorders, increasing screen time, aging population, rising awareness for eye health, availability of optical care services, and demand for corrective eyewear. According to IMARC Group's latest research publication, The global vision care market size was valued at USD 73.73 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 94.33 Billion by 2033, exhibiting a CAGR of 2.75% from 2025-2033.

How AI is Reshaping the Future of Vision Care Market

  • Artificial intelligence (AI) systems can be used to develop frames and lenses based on the person's face shape, bone measurements, and preferred style of eyewear. Computer vision AI which 3D scans the face can use these scans to recommend designs that provide a better fit and fewer returns.
  • Machine learning is also used to analyze retinal photographs and other imaging tests to diagnose diabetic retinopathy, glaucoma, and macular degeneration at an earlier stage and with fewer false positives, speeding up the process while lowering the risk of complications or blindness.
  • AI virtual try-on helps consumers try on hundreds of styles of eyewear within seconds, creating a more personalized retail experience, increasing online sales, reducing foot traffic to physical retail locations, and giving consumers confidence to purchase eyewear online.

Access Updated Market Insights in a Free Sample Report

Vision Care Industry Overview:

With over 45% market share, North America has the highest share due to its infrastructure and spending. According to the CDC, there are about 12 million adults in North America aged 40 years or older with a vision impairment. 75% of adults worldwide need refractive correction, and the World Health Organization announced in May 2024 that it is launching SPECS 2030, seeking to increase spectacles access by 40%. Malaysia, Indonesia and China have national plans. In the US, Kian Capital Partners and RF Investment Partners formed a new company named US VisionMed Partners, which continued operating existing optometry practices and created a management services organization for expanded medical services.

Vision Care Market Trends & Drivers:

Screen time, computers and other technology have become more common. An average American spends 7 hours each day using an electronic device. Symptoms of digital eye strain include discomfort or decrease in productivity. A Chinese study found 89.7% of senior-high and 78.2% of junior-high students are myopic. This high incidence has resulted in a strong demand for blue light filtering lenses, anti-reflective lenses and computer lenses.

Another important market demographic is seniors. The World Health Organization estimates that by 2030, there will be 1.4 billion people aged 60 years or older. Cataracts, age-related macular degeneration, glaucoma, and presbyopia are other eye diseases that increase with age, require frequent screening, and are sometimes managed with specialist care. In India, about 6 million cataract surgeries are performed annually as part of the National Programme for Control of Blindness.

Vision care may be covered by government programs or provided through access to health care. The World Health Organization (WHO) has a vision care program called SPECS 2030. Only 36% of people who need refractive error correction have it. EssilorLuxottica Foundation and WHO's vision care scale-up in aspirational blocks of India, uses Karnataka's ASHA Kirana model. In October 2024, Indonesia announced an initiative called SPECS 2030 to improve access to affordable glasses through the primary health care system.

Leading Companies Operating in the Global Vision Care Industry:

  • Alcon Inc.
  • Bausch Health Companies Inc.
  • CooperVision
  • Essilor
  • EssilorLuxottica
  • HOYA Corporation
  • Johnson & Johnson Vision Care, Inc.
  • Menicon
  • ZEISS Vision

Vision Care Market Report Segmentation:

By Product Type:

  • Glass Lenses
  • Contact Lenses
  • Intraocular Lenses
  • Contact Solutions
  • LASIK Equipment
  • Artificial Tears

Glass lenses lead the market with around 35.8% market share, driven by their durability, scratch resistance, affordability, and excellent UV protection addressing refractive errors effectively.

By Distribution Channel:

  • Retail Stores
  • Online Stores
  • Clinics
  • Hospitals

Retail stores dominate with approximately 38.6% market share, offering unparalleled accessibility, immersive shopping experiences, and comprehensive product ranges under one roof for consumer convenience.

Regional Insights:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

North America exhibits clear dominance with 45.6% market share due to advanced healthcare infrastructure, cutting-edge technologies, and strong consumer investment in premium eye care services.

Recent News and Developments in Vision Care Market

  • In October 2025, ZEISS Vision Care entered into a binding agreement to acquire a 10% equity stake from the Fielmann Group in the German optical technology firm Ocumeda AG, potentially rising to a 25% stake.
  • In October 2025, the WHO and the OneSight EssilorLuxottica Foundation announced a partnership to expand access to eye health services in NITI Aayog aspirational blocks across India, as part of WHO's global SPECS 2030 initiative to expand refractive coverage by 40% by 2030 through integration into primary health care for underserved populations.
  • In August 2025, Staar Surgical Co agreed to be acquired for USD 1.5 billion by Alcon Inc in an all cash offer of USD 28 per share, a 51% premium. The acquisition grants Alcon the Implantable Collamer Lenses technology to provide minimally intrusive vision correction solutions.
  • August 2025: In Series A, eyebot raised USD 20 million in a round led by General Catalyst, with AlleyCorp, Baukunst, Village Global, and Ubiquity Ventures participating in the financing round, which it will use to deploy kiosks across hundreds of retail stores, grow its clinical and engineering teams, and expand its partnerships with eye care providers.
  • In June 2025, Carl Zeiss Vision International GmbH signed a definitive agreement to acquire 100 percent of shares of Brighten Optix, a Taipei Exchange listed-spectrum manufacturer of orthokeratology and specialty contact lenses. The acquisition strengthens the ZEISS Vision Care portfolio in the field of myopia management and acts as a basis for planned long-term growth.

Note: If you require specific details, data, or insights that are not currently included in the scope of this report, we are happy to accommodate your request. As part of our customization service, we will gather and provide the additional information you need, tailored to your specific requirements. Please let us know your exact needs, and we will ensure the report is updated accordingly to meet your expectations.

buyers guide

About the Creator

James Whitman

With years of experience in analyzing global industries, I specialize in delivering actionable market insights that help businesses stay ahead in an ever-changing landscape.

Reader insights

Be the first to share your insights about this piece.

How does it work?

Add your insights

Comments

There are no comments for this story

Be the first to respond and start the conversation.

Sign in to comment

    Find us on social media

    Miscellaneous links

    • Explore
    • Contact
    • Privacy Policy
    • Terms of Use
    • Support

    © 2026 Creatd, Inc. All Rights Reserved.